Sequana Medical receives CE Mark Approval for the ALFApump System and adds Key Executive to Team
Zurich, Switzerland (ots) - New technology expands treatment options for patient with refractory ascites due to liver cirrhosis. Dr. Farzana Malik joins as Vice President of Market Access and Reimbursement. Sequana Medical announced today that it has received CE Mark approval for the commercial sale of its ALFApump System. Over the coming months, the company will ...